Volume 7: Issue 5-6, May 2016
pp148-217
 |
About the CoverThe cover for the issue of Genes&Cancer features Figure 5A (“Short-form Ron is a novel determinant of ovarian cancer initiation and progression”) from Moxley et al. |
Technical Report
A chemoproteomic method for identifying cellular targets of covalent kinase inhibitors
https://doi.org/10.18632/genesandcancer.106
Ying-Chu Chen, and Chao Zhang
p 148-153
Research Papers
MUC4 is negatively regulated through the Wnt/β-catenin pathway via the Notch effector Hath1 in colorectal cancer
https://doi.org/10.18632/genesandcancer.108
Priya Pai, Satyanarayana Rachagani, Punita Dhawan, Yuri M. Sheinin, Muzafar A. Macha, Asif Khurshid Qazi, Seema Chugh, Moorthy P. Ponnusamy, Kavita Mallya, Ramesh Pothuraju, and Surinder K. Batra
p 154-168
Short-form Ron is a novel determinant of ovarian cancer initiation and progression
https://doi.org/10.18632/genesandcancer.109
Katherine M. Moxley, Luyao Wang, Alana L. Welm, and Magdalena Bieniasz
p 169-181
Genetic determinants in head and neck squamous cell carcinoma and their influence on global personalized medicine
https://doi.org/10.18632/genesandcancer.110
Nicole L. Michmerhuizen, Andrew C. Birkeland, Carol R. Bradford, and J. Chad Brenner
p 182-200
Combination of JAK2 and HSP90 inhibitors: an effective therapeutic option in drug-resistant chronic myelogenous leukemia
https://doi.org/10.18632/genesandcancer.111
Sandip N. Chakraborty, Xiaohong Leng, Bastianella Perazzona, Xiaoping Sun, Yu-Hsi Lin, and Ralph B. Arlinghaus
p 201-208
Melatonin decreases estrogen receptor binding to estrogen response elements sites on the OCT4 gene in human breast cancer stem cells
https://doi.org/10.18632/genesandcancer.107
Juliana Lopes, David Arnosti, James E. Trosko, Mei-Hui Tai, and Debora Zuccari
p 209-217